-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Claritev, Raises Price Target to $40

Benzinga·08/21/2026 15:05:15
语音播报
Barclays analyst Glen Santangelo maintains Claritev (NYSE:CTEV) with a Overweight and raises the price target from $28 to $40.